ANGO
AngioDynamics, Inc.
ANGO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
ANGO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
ANGO's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
ANGO PE Valuation
ANGO has no meaningful PE right now: it lost money over the past year.
ANGO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect ANGO's losses to shrink, with revenue growing.
ANGO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.79 | -$0.01 |
| Q2 2026 | -$0.88 | -$0.05 |
| Q1 2026 | -$0.75 | +$0.28 |
| Q4 2025 | -$0.67 | +$4.92 |
| Q3 2025 | -$0.78 | +$5.27 |
| Q2 2025 | -$0.83 | +$3.76 |
| Q1 2025 | -$1.03 | +$3.76 |
| Q4 2024 | -$5.59 | -$5.23 |
ANGO is still losing money, but far less than before: $0.79 per share over the past year, against $6.05 at its worst in mid-2024.
ANGO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $80.9M | +6.9% |
| Q2 2026 | $86.6M | +8% |
| Q1 2026 | $78.4M | +8.9% |
| Q4 2025 | $79.4M | +9% |
| Q3 2025 | $75.7M | +12% |
| Q2 2025 | $80.2M | +13% |
| Q1 2025 | $72M | -4.2% |
| Q4 2024 | $72.8M | -7.9% |
ANGO's revenue has grown year over year for six quarters in a row: $81M last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9% | +5.1 points |
| Q2 2026 | -12% | -4.5 points |
| Q1 2026 | -17% | -2.7 points |
| Q4 2025 | -7.7% | +7.5 points |
| Q3 2025 | -14% | +5.3 points |
| Q2 2025 | -7.2% | +13 points |
| Q1 2025 | -14% | +252 points |
| Q4 2024 | -15% | +1.4 points |
ANGO's operating margin was −9% last quarter, up 5.1 points from the same quarter a year ago.
ANGO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.7M | +$936K |
| Q2 2026 | $17M | -5.5% |
| Q1 2026 | -$4.1M | +$10.8M |
| Q4 2025 | $4.2M | +153% |
| Q3 2025 | -$16.6M | +$2.7M |
| Q2 2025 | $18M | +307% |
| Q1 2025 | -$15M | -$1.8M |
| Q4 2024 | $1.7M | -64% |
ANGO's free cash flow has turned positive after two years mostly in the red: $1M over the past year.
ANGO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +496K shares |
| 1 year | +2.1% | +848K shares |
| 3 years | +5.1% | +2.1M shares |
| 5 years | +8.5% | +3.3M shares |
| Available history | +11% | +4M shares |
ANGO has 42M diluted shares, up 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $1.1M |
| Q3 2024 | $552,000 |
ANGO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -2.9x | Net Cash |
| Q3 2023 | -2.1x | Net Cash |
| Q2 2022 | -32.8x | Net Cash |
| Q4 2019 | -6.1x | Net Cash |
ANGO has more cash than debt.
ANGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.7 | Neutral |
| Stochastic | 22.6 | Neutral |
ANGO's weekly RSI is 43 (neutral) and its Stochastic is 23 (neutral).
ANGO PE vs Healthcare Sector
| Metric | ANGO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ANGO has no meaningful PE right now: it lost money over the past year.
ANGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.7 | 5.5% below |
| 20 week MA | $13.9 | 14% below |
| 50 week MA | $12.4 | 3.4% below |
| 100 week MA | $11.3 | 5.7% above |
| 200 week MA | $9.60 | 25% above |
ANGO has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 25% above its 200-week average.
ANGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.0 | $14.1 | -11% |
| 2021 | $14.1 | $28.2 | +100% |
| 2022 | $28.2 | $13.3 | -53% |
| 2023 | $13.3 | $7.84 | -41% |
| 2024 | $7.84 | $8.91 | +14% |
| 2025 | $8.91 | $13.1 | +47% |
| 2026 YTD | $13.1 | $12.0 | -8.5% |
ANGO has finished lower in three of the last six years. It's down 8.5% so far in 2026.